Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

Developments in health technology allow us to take more personal responsibility for our wellbeing, which may have significant ...

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just ...

We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology 2 as our first CGM partner, marking a significant milestone as we bring our ...

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

Researchers from the University of Bath, UK, compared the results of one brand of CGM with the gold-standard finger prick test when measuring the blood glucose levels of 15 non-diabetic people.

A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous ...

CMA CGM is in talks with shipyards about the possibility of having medium-sized container vessels built in the United States, the French shipping group's CEO Rodolphe Saade told Les Echos newspaper.